Modern Vaccines Adjuvants Formulation (MVAF) 2016

The increasing need for new and improved vaccines and the growing level of sophistication of their associated adjuvantation and delivery systems has major implications for the design, formulation, delivery, manufacturing and quality assessment of modern vaccines and immune interventions in general. MVAF 2016 will be the fifth meeting in this successful series and again will offer an international forum for the discussion of all aspects of vaccine and adjuvant formulation and will focus on:

Innovation in vaccine design and adjuvantation/delivery technologies Challenges to manufacturing and the administration of modern vaccines Compliance with quality standards and regulatory requirements

MVAF 2016 will then assess the impact of all of the above on the future development/design of vaccines and adjuvants.

MVAF 2016 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.